ライフサイエンスコーパス: infectious anemia

1 h that some animals exhibited chronic equine infectious anemia, characterized by multiple disease epi

2 lones induced clinical signs of acute equine infectious anemia (EIA) at 23 days postinfection (dpi).

3 Control of equine infectious anemia (EIA) is currently based on detection

4 elial cell infection in the course of equine infectious anemia is currently unknown, but endothelial

5 Chicken infectious anemia virus (CIAV) is a unique infectious ag

6 us (contained in its p2b sequence) or equine infectious anemia virus (contained in p9).

7 ototype YPDL-type L domain encoded by equine infectious anemia virus (EIAV) acts by recruiting AIP-1/

8 l NES-containing Rev-like proteins of equine infectious anemia virus (EIAV) and feline immunodeficien

9 uman immunodeficiency virus (HIV) and equine infectious anemia virus (EIAV) are closely related lenti

10 Permeabilized preparations of equine infectious anemia virus (EIAV) are shown here to support

11 This study, using CA proteins from equine infectious anemia virus (EIAV) as an example, demonstrat

12 s disrupted by proteasome inhibitors, equine infectious anemia virus (EIAV) budding is not affected b

13 A novel strain of equine infectious anemia virus (EIAV) called vMA-1c that rapidl

14 deficiency virus type one (HIV-1) and equine infectious anemia virus (EIAV) capsid proteins, although

15 Since the L domain of equine infectious anemia virus (EIAV) contains a Yxxtheta motif

16 Equine infectious anemia virus (EIAV) contains the simplest gen

17 (LTR) of macrophage-tropic strains of equine infectious anemia virus (EIAV) contains three PU.1 bindi

18 ar clones pSPeiav19 and p19/wenv17 of equine infectious anemia virus (EIAV) differ in env and long te

19 t study examined the entry pathway of equine infectious anemia virus (EIAV) during infection of its n

20 The lentivirus equine infectious anemia virus (EIAV) encodes the small protein

21 directly, we examined the patterns of equine infectious anemia virus (EIAV) envelope variation during

22 Here we show that the budding of equine infectious anemia virus (EIAV) from infected equine cell

23 ith transfected cells reveal that the equine infectious anemia virus (EIAV) Gag p9 protein provides a

24 While activation of equine infectious anemia virus (EIAV) gene expression by the EI

25 functionally distinct regions of the equine infectious anemia virus (EIAV) genome (env, rev, and lon

26 ine immunodeficiency virus (FIV), and equine infectious anemia virus (EIAV) genomic RNA.

27 t a lentiviral vector system based on equine infectious anemia virus (EIAV) gives rise to highly effi

28 sequence variation of the lentivirus equine infectious anemia virus (EIAV) has not been explored.

29 The entry mechanism of equine infectious anemia virus (EIAV) has yet to be examined.

30 nant p26 capsid protein (CA) from the equine infectious anemia virus (EIAV) have in common an antipar

31 ommon assembly mechanisms, studies of equine infectious anemia virus (EIAV) have indicated alternativ

32 irus and envelope subunit vaccines to equine infectious anemia virus (EIAV) have revealed a broad spe

33 Equine infectious anemia virus (EIAV) infection of horses is ch

34 Equine infectious anemia virus (EIAV) infection of horses is ch

35 pic murine leukemia virus (N-MLV) and equine infectious anemia virus (EIAV) infection, promotion of h

36 The control of equine infectious anemia virus (EIAV) infections of horses has

37 have demonstrated that the lentivirus equine infectious anemia virus (EIAV) infects tissue macrophage

38 Entry of wild-type lentivirus equine infectious anemia virus (EIAV) into cells requires a low

39 Equine infectious anemia virus (EIAV) is a lentivirus that caus

40 Equine infectious anemia virus (EIAV) is a lentivirus with in v

41 In contrast, the YPDL L domain of equine infectious anemia virus (EIAV) is apparently unique in i

42 monstrated that the Gag p9 protein of equine infectious anemia virus (EIAV) is functionally homologou

43 Equine infectious anemia virus (EIAV) is genetically one of the

44 Persistent infection of equids by equine infectious anemia virus (EIAV) is typically characterize

45 Equine infectious anemia virus (EIAV) is unique among enveloped

46 nodeficiency virus type 1 (HIV-1) and equine infectious anemia virus (EIAV) L domain-derived peptides

47 identified an interaction between the equine infectious anemia virus (EIAV) late assembly domain and

48 uman immunodeficiency virus (HIV) and equine infectious anemia virus (EIAV) lentiviral vectors in a v

49 Using the equine infectious anemia virus (EIAV) lentivirus model system,

50 ation of the naturally unmyristylated equine infectious anemia virus (EIAV) MA and its interaction wi

51 om a horse persistently infected with equine infectious anemia virus (EIAV) neutralized homologous vi

52 The equine infectious anemia virus (EIAV) often results in lifelong

53 We examined equine infectious anemia virus (EIAV) particles and found that

54 uman immunodeficiency virus (HIV) and equine infectious anemia virus (EIAV) particles.

55 Wild-type strains of equine infectious anemia virus (EIAV) prevent superinfection of

56 Equine infectious anemia virus (EIAV) provides a natural model

57 Equine infectious anemia virus (EIAV) provides a uniquely dynam

58 us (BIV), maedi-visna virus (MVV) and equine infectious anemia virus (EIAV) readily interacted with L

59 nd another data set consisting of the equine infectious anemia virus (EIAV) regulatory gene rev.

60 Equine infectious anemia virus (EIAV) Rev is an essential regul

61 of incompletely spliced viral mRNAs, equine infectious anemia virus (EIAV) Rev regulates alternative

62 icant variation in the second exon of equine infectious anemia virus (EIAV) rev.

63 l truncation of the Gag p9 protein of equine infectious anemia virus (EIAV) revealed a progressive lo

64 Two variants of equine infectious anemia virus (EIAV) that differed in sensitiv

65 ficiency virus mac239 (SIVmac239) and equine infectious anemia virus (EIAV) the most dependent and hu

66 We employed the equine lentivirus equine infectious anemia virus (EIAV) to investigate the cellul

67 All lentiviruses except equine infectious anemia virus (EIAV) use the small accessory p

68 ing assays that the Gag p9 protein of equine infectious anemia virus (EIAV) utilizes a unique YPDL mo

69 A highly effective attenuated equine infectious anemia virus (EIAV) vaccine (EIAV(D9)) capabl

70 thogenic molecular clone (19-2-6A) of equine infectious anemia virus (EIAV) was modified by substitut

71 ag/Pr or SU protein of the lentivirus equine infectious anemia virus (EIAV) were constructed and used

72 udied the full-length CA protein from equine infectious anemia virus (EIAV), a lentivirus sharing the

73 Equine infectious anemia virus (EIAV), a macrophage-tropic lent

74 cious subunit peptide vaccine against equine infectious anemia virus (EIAV), a naturally occurring le

75 A Tyr-Pro-Asp-Leu (YPDL) motif in equine infectious anemia virus (EIAV), and a related sequence i

76 nodeficiency virus type 1 (HIV-1) and equine infectious anemia virus (EIAV), and inhibits the accumul

77 erimental live attenuated vaccine for equine infectious anemia virus (EIAV), based on mutation of the

78 Human cells restrict N-MLV and equine infectious anemia virus (EIAV), but not HIV-1, HIV-2, SI

79 the ungulate lentiviruses, including equine infectious anemia virus (EIAV), exclusively infect cells

80 bovine immunodeficiency virus (BIV), equine infectious anemia virus (EIAV), feline immunodeficiency

81 of a naturally occurring lentivirus, equine infectious anemia virus (EIAV), occurs in most infected

82 feline immunodeficiency virus (FIV), equine infectious anemia virus (EIAV), or N-tropic murine leuke

83 Equine infectious anemia virus (EIAV), uniquely among lentiviru

84 Using equine infectious anemia virus (EIAV), we now demonstrate diffe

85 StarGen is an equine infectious anemia virus (EIAV)-based lentiviral vector t

86 Most equine infectious anemia virus (EIAV)-infected horses have acut

87 ative splicing of the tat/rev mRNA of equine infectious anemia virus (EIAV).

88 infection of horses by the lentivirus equine infectious anemia virus (EIAV).

89 on of a distantly related lentivirus, equine infectious anemia virus (EIAV).

90 modification by the lentiviral vector equine infectious anemia virus (EIAV).

91 entified as a functional receptor for equine infectious anemia virus (EIAV).

92 deficiency virus, type 1 (HIV-1), and equine infectious anemia virus (EIAV).

93 into the heterologous Gag protein of equine infectious anemia virus (EIAV).

94 eno-associated virus 2 (AAV2)/GDNF or equine infectious anemia virus (EIAV)/GDNF into the caudate.

95 The Rev protein of equine infectious anemia virus (ERev) exports unspliced and par

96 ndent budding previously observed for equine infectious anemia virus (plasma membrane assembly, YPDL

97 d that pseudotyping of the nonprimate equine infectious anemia virus (using the lentivector gene tran

98 mmunodeficiency virus type 1 [HIV-1], equine infectious anemia virus [EIAV]) and unrestricted (NB-tro

99 Foals infected with equine infectious anemia virus become thrombocytopenic 7 to 20

100 to the YPDL late domain found in the equine infectious anemia virus Gag protein.

101 Equine infectious anemia virus is a lentivirus that replicates

102 iation of Alix 364-716 with HIV-1 and equine infectious anemia virus late domains was quantitatively

103 y the 55-amino acid form (NC55) or by equine infectious anemia virus NC.

104 nodeficiency virus type 1 (HIV-1) and equine infectious anemia virus particle production.

105 T-cell leukemia virus type 1 Rex, and equine infectious anemia virus Rev but not with functionally in

106 rted by the 66 and 51 kDa subunits of equine infectious anemia virus reverse transcriptase (EIAV RT),

107 m underlying this event, catalyzed by equine infectious anemia virus reverse transcriptase (EIAV RT),

108 a successful experimental attenuated equine infectious anemia virus vaccine, derived by mutation of

109 ruses, including HIV-1 (but excluding equine infectious anemia virus), encode a viral infectivity fac

110 human immunodeficiency virus type 1, equine infectious anemia virus, and adenovirus L1 3' processing

111 HIV-2, bovine immunodeficiency virus, equine infectious anemia virus, and feline immunodeficiency vir

112 or control of lentiviruses, including equine infectious anemia virus, relatively little is known rega

113 primate lentiviruses, visna virus and equine infectious anemia virus, revealed that their activation

114 s pre-steady-state kinetic studies of equine infectious anemia virus-1 (EIAV) reverse transcriptase (

115 es that present important epitopes to equine infectious anemia virus-specific CTL.

116 escape data from horses infected with equine infectious anemia virus.

117 Ponies were infected with equine infectious anemia virus.

118 roperties of the LYPDL late domain of equine infectious anemia virus.

119 st N-tropic murine leukemia virus and equine infectious anemia virus.

120 experimental infection of ponies with equine infectious anemia virus.

121 n ponies experimentally infected with equine infectious anemia virus.

122 (Tat) from human immunodeficiency and equine infectious anemia viruses (HIV and EIAV) interact with t

123 iptases of human immunodeficiency and equine infectious anemia viruses.